BioCentury
ARTICLE | Company News

BalChem Corp., CureMark deal

November 20, 2006 8:00 AM UTC

CureMark received an exclusive license to BCP's PharmaShure drug delivery technology for use in CureMark's digestive and pancreatic enzyme products. The company expects its lead products in autism and...